382 related articles for article (PubMed ID: 15125776)
21. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil.
Choi MK; Song IS
J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210
[TBL] [Abstract][Full Text] [Related]
22. Efflux and uptake transporters involved in the disposition of bazedoxifene.
Lušin TT; Mrhar A; Stieger B; Kristl A; Berginc K; Trontelj J
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):251-7. PubMed ID: 25631963
[TBL] [Abstract][Full Text] [Related]
23. Transepithelial transport of fusariotoxin nivalenol: mediation of secretion by ABC transporters.
Tep J; Videmann B; Mazallon M; Balleydier S; Cavret S; Lecoeur S
Toxicol Lett; 2007 May; 170(3):248-58. PubMed ID: 17481833
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
[TBL] [Abstract][Full Text] [Related]
25. The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s).
Gupta E; Luo F; Lallo A; Ramanathan S; Vyas V; Rubin E; Sinko P
Anticancer Res; 2000; 20(2A):1013-6. PubMed ID: 10810389
[TBL] [Abstract][Full Text] [Related]
26. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
27. Assessment and modulation of forsythiaside absorption with MDCKII cells and validation with in situ intestinal experiment.
Li YX; Zhang RQ; Peng C
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):179-86. PubMed ID: 22430364
[TBL] [Abstract][Full Text] [Related]
28. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.
Prime-Chapman HM; Fearn RA; Cooper AE; Moore V; Hirst BH
J Pharmacol Exp Ther; 2004 Nov; 311(2):476-84. PubMed ID: 15210835
[TBL] [Abstract][Full Text] [Related]
29. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.
Lowes S; Simmons NL
Br J Pharmacol; 2002 Mar; 135(5):1263-75. PubMed ID: 11877335
[TBL] [Abstract][Full Text] [Related]
30. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
[TBL] [Abstract][Full Text] [Related]
31. In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs.
Yu L; Shen Q; Zhou Q; Jiang H; Bi H; Huang M; Zhou H; Zeng S
J Ethnopharmacol; 2013 Nov; 150(2):485-91. PubMed ID: 24036064
[TBL] [Abstract][Full Text] [Related]
32. Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2.
Letschert K; Komatsu M; Hummel-Eisenbeiss J; Keppler D
J Pharmacol Exp Ther; 2005 May; 313(2):549-56. PubMed ID: 15665139
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
Hoffmann K; Löscher W
Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
[TBL] [Abstract][Full Text] [Related]
34. Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats.
Arimori K; Kuroki N; Hidaka M; Iwakiri T; Yamsaki K; Okumura M; Ono H; Takamura N; Kikuchi M; Nakano M
Pharm Res; 2003 Jun; 20(6):910-7. PubMed ID: 12817897
[TBL] [Abstract][Full Text] [Related]
35. Effect of probenecid on the biliary excretion of belotecan.
Namkoong EM; Kim IW; Kim DD; Chung SJ; Shim CK
Arch Pharm Res; 2007 Nov; 30(11):1482-8. PubMed ID: 18087819
[TBL] [Abstract][Full Text] [Related]
36. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
[TBL] [Abstract][Full Text] [Related]
37. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
Bourdet DL; Thakker DR
Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
39. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
40. Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells.
Yamamoto W; Verweij J; de Bruijn P; de Jonge MJ; Takano H; Nishiyama M; Kurihara M; Sparreboom A
Anticancer Drugs; 2001 Jun; 12(5):419-32. PubMed ID: 11395570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]